Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas.
about
Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-AnalysisIs Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with ChemotherapyCurrent status and progress of pancreatic cancer in ChinaNetwork meta-analysis of Chinese herbal injections combined with the chemotherapy for the treatment of pancreatic cancer.Anti-proliferative of physcion 8-O-β-glucopyranoside isolated from Rumex japonicus Houtt. on A549 cell lines via inducing apoptosis and cell cycle arrest.Extract of Artemisia lavandulaefolia Inhibits In Vitro Angiogenesis in Human Umbilical Vein Endothelial Cells.In vitro and in vivo antitumor activity of scutebarbatine A on human lung carcinoma A549 cell lines.Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor CellsErlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trialEvaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer Therapy.Phase II clinical trials on investigational drugs for the treatment of pancreatic cancersTreatment of Huge Hepatocellular Carcinoma Using Cinobufacini Injection in Transarterial Chemoembolization: A Retrospective Study.Multiple effects of Xihuang pill aqueous extract on the Hs578T triple-negative breast cancer cell line.Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment.Cinobufagin exerts anti-proliferative and pro-apoptotic effects through the modulation ROS-mediated MAPKs signaling pathway.A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy.The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasLTraditional Chinese medicine for cancer?The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment.Chloroform fraction of Serratulae chinensis S. Moore suppresses proliferation and induces apoptosis via the phosphatidylinositide 3-kinase/Akt pathway in human gastric cancer cells.Resibufogenin suppresses transforming growth factor-β-activated kinase 1-mediated nuclear factor-κB activity through protein kinase C-dependent inhibition of glycogen synthase kinase 3The Development of Toad Toxins as Potential Therapeutic Agents
P2860
Q26774931-745567F7-AE46-4DDA-82C5-1BA8661782A4Q26782755-9D236B32-A338-4D10-9079-5267FD77EA42Q26799739-7A39DE4B-7E7E-47A0-9189-0B99E2BA520DQ33760649-9CBA895A-C919-40BC-A286-CC4E30CFE2EFQ34363051-30C49F68-7F37-4E1D-A9A3-DF9036C31741Q34853120-FC522DAC-FA9B-45C1-8901-A7A0DF9DA485Q35195781-EBC8805F-8AC2-4703-8A1C-99D60A6B93F7Q35677008-07D7C2AB-54EA-40BB-856F-3CF2A1EC2CA6Q36228534-29EE1A75-9330-44DD-AACA-C966900AB3BAQ36247497-A83A2DFA-B607-4CB0-AC2E-D8D529DFA14AQ36384541-82A6180A-573C-4DF8-A00F-65AF8A7F9331Q36949130-13FCDFB2-AA94-4526-8A74-5B74FB15715CQ37406281-CF9FC6F0-7F07-4EDE-A3C5-E14315F7994CQ38367657-E1252F13-B66F-4AD3-A405-AAB94C0AF69FQ38873783-B26AD15F-6102-427D-A1E0-37B0B36BEC43Q40766189-6ECE18D1-A441-47EE-8E0E-5DAF6B5288E4Q41134742-60A710DD-B3B6-4FC0-8AB3-074A5B5DC896Q43232089-F17A39E1-13F9-4A6F-BCC9-DECC9C68E9EBQ48056210-FFD507DE-0E59-4C8A-A8C2-AAC6B0F7F2D1Q55397916-9AF6D328-C7A4-4B22-A367-D43B03CCE772Q58701699-9FFBFACE-33C5-4BB4-BC19-08A55589E0A8Q58734595-5C962A40-D4B4-478E-8FD9-0C3E2880D3DF
P2860
Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prospective randomised evaluat ...... ed pancreatic adenocarcinomas.
@ast
Prospective randomised evaluat ...... ed pancreatic adenocarcinomas.
@en
type
label
Prospective randomised evaluat ...... ed pancreatic adenocarcinomas.
@ast
Prospective randomised evaluat ...... ed pancreatic adenocarcinomas.
@en
prefLabel
Prospective randomised evaluat ...... ed pancreatic adenocarcinomas.
@ast
Prospective randomised evaluat ...... ed pancreatic adenocarcinomas.
@en
P2093
P2860
P356
P1476
Prospective randomised evaluat ...... ed pancreatic adenocarcinomas.
@en
P2093
A R Spelman
C R Garrett
P2860
P2888
P304
P356
10.1038/BJC.2012.283
P407
P577
2012-07-10T00:00:00Z